Refractory Soft Tissue Sarcoma
Oncology
Prevalence
30.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Refractory Soft Tissue Sarcoma?
There are 2 clinical trials targeting Refractory Soft Tissue Sarcoma tracked by BioSniper.
What is the prevalence of Refractory Soft Tissue Sarcoma?
The estimated prevalence of Refractory Soft Tissue Sarcoma is approximately 30.0 per 100,000 population.
Deep-dive into Refractory Soft Tissue Sarcoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis